The incidence of cervical adenocarcinoma is increasing, particularly in women of reproductive age, and presents a unique diagnostic and therapeutic challenge when encountered during pregnancy.
Distinguishing malignant cervical lesions from benign entities such as nabothian cysts can be particularly difficult due to overlapping clinical and imaging features, leading to potential delays in diagnosis and management.
